|Articles|April 23, 2020
COVID-19: Sun Pharmaceuticals business update
Author(s)Mark Hagler
Advertisement
Mark Hagler, senior vice president, head of Ophthalmics, Oncology and LTC, at Sun Pharmaceuticals, shares a business update on how the company has responded and continued operations during the coronavirus pandemic.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Refractory dry eye care: How systemic conditions change the game
2
The year in optometry: 10 stories that defined eye care in 2025
3
Glaucoma 2026: Which emerging technologies will change practice?
4
Reflections from the floor: AAO memories that shaped careers
5